ArticleExperimental and therapeutic medicine2024

Bilobalide attenuates lipopolysaccharide‑induced HepG2 cell injury by inhibiting TLR4‑NF‑κB signaling via the PI3K/Akt pathway.

Shumei Mao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.